Back to results
US 2010/0249082 A1Published application
Modulators of hypoxia inducible factor-1 and related uses
AssigneeBionaut Pharmaceuticals, Inc.
InventorsHans-Jurgen Hess, Sajjat Hussoin, Oliver Schwarz
Life of this patent
Estimating the term…
Abstract
The invention features compounds of formula (I): and pharmaceutically acceptable salts and prodrugs thereof, as well methods for modulating the effects of local and systemic hypoxic events using the compounds.
Claims11
A compound of formula I:
- or a pharmaceutically acceptable salt or prodrug thereof, wherein:
- R is a nitrogen-containing C2-6 heterocyclyl group joined to the (CH2)n linkage by means of its nitrogen atom and optionally substituted with a C1-5 alkyl, C1-5 hydroxyalkyl, C1-5 halogenoalkyl or C1-5 acyl group, a phenyl group or a C1-5 alkyl group further substituted with a phenyl group,
- R is a group R′R″N— with R′ and R″ independently equal to H, C1-5 alkyl or methylenecyclopropyl, and
- n is an integer in the range 2 to 5,
- with the proviso that, when R represents an unsubstituted piperidino group or a dimethylamino group, then n does not equal 2.
2 more elements
Dependencies are inferred from the claim text.